[Current approaches of treatment for myelodysplastic syndrome (MDS)].

@article{Lewandowski1995CurrentAO,
  title={[Current approaches of treatment for myelodysplastic syndrome (MDS)].},
  author={Krzysztof Lewandowski and Joanna Goździk and Janusz Hansz},
  journal={Acta haematologica Polonica},
  year={1995},
  volume={26 4},
  pages={333-41}
}
The number of treatment modalities for patients with myelodysplastic syndromes (MDS) has increased, but curative options are still limited. For the majority of patients with low risk there is no standard therapy other than appropriate supportive care. In selected patients anabolic steroids, differentiation inducers such as cis-retinoic acid (RA), interferon… CONTINUE READING